ClinicalTrialsFinder

Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer Clinical Trials in Washington D.C., District of Columbia

1 recruitingWashington D.C., District of Columbia

Showing 1–1 of 1 trials

Recruiting
Phase 2

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

Breast CancerPretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Criterium, Inc.30 enrolled6 locationsNCT05458674